Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated
The first-ever phase three clinical trial for India’s indigenous tetravalent dengue vaccine, DengiALL has been initiated. DengiALL has been developed by Panacea Biotec. Currently, there is no antiviral treatment or …
